Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

Post by MartialArtson Jan 20, 2018 11:25am
190 Views
Post# 27400636

Comparing ACB at $13.48 with CMED at $1.88

Comparing ACB at $13.48 with CMED at $1.88
One of the very, very common problems novices have is evaluating and comparing share prices.  Talk to anyone new to investing or trading and everyone has the same issue.  It's part of the "maturing" process on the markets.  Once you can evaluate a company on market cap and enterprise value, you can shed off the "newbie" moniker.

In order to compare two companies on equal footing, you need to compare them with the same number of issued shares.  That seems to be the best way to do it.

So Aurora has a market cap of $6.10B with 452.73M shares issued so the share price is $6100M/452.7 = $13.48 per share.

Now to compare Cannimed share price to Aurora, we really need to use the same number of issued shares otherwise we are comparing difference coins (loonies to nickels where CMED is denominated in loonies and ACB is denominated in nickels).  Or "apples to oranges".

So taking Cannimed's market cap of $849M with the same ACB share count of 452.73M, we get
$849M/452.73m shares= $1.88 per share comparing apples to apples.  Or total market cap denominated in nickels.

Hope that makes sense.  If you have any questions please send me a message if you are scare to be riduculed.  Everyone has been a newbie at some point in their lives.  Nobody is born with this knowledge.
<< Previous
Bullboard Posts
Next >>